DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹34 Cr | ₹30 Cr | ₹24 Cr | ₹20 Cr | ₹26 Cr |
What is the latest Long Term Provisions ratio of DR REDDYS LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹34 Cr |
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹26 Cr |
How is Long Term Provisions of DR REDDYS LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹34 Cr | 13.42 | |
| Mar2025 | ₹30 Cr | 24.69 | |
| Mar2024 | ₹24 Cr | 20.10 | |
| Mar2023 | ₹20 Cr | -22.87 | |
| Mar2022 | ₹26 Cr | - | |
Compare Long Term Provisions of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹111,724.6 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
| MANKIND PHARMA | ₹101,659.0 Cr | 11% | 0.9% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 9.3% |
9.5% |
4.3% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses